(a)
(b)
(c)
(d)
Figure 1: Expression of adipose tissue IL-33 and ST2 among individuals with varying degrees of glycemia. (a) There was no difference in the level of IL-33 among individuals with normoglycemia, prediabetes, or T2D. (b) There was no difference in the level of ST2 among individuals with normoglycemia, prediabetes, or T2D. (c) There was no difference in the level of IL-33 among individuals with T2D and varying degrees of glycemic control. (d) There was no difference in the level of ST2 among individuals with T2D and varying degrees of glycemic control. IL-33: interleukin-33; ST2: suppressor of tumorigenicity 2; HbA1c: glycated hemoglobin; T2D: type 2 diabetes; Meds: glucose-lowering medications.